Carol L Remmers, J. Hibbard, D. Mosen, Morton Wagenfield, R. E. Hoye, Ches S. Jones
tlooto Summary
The PAM was predictive for hemoglobin A1c testing, but not for lipid-lowering drug use, LDL-C control, or acute myocardial infarction discharges, suggesting that PAM scores can be used to identify patients at risk for poorer health outcomes.
Abstract
We examined the relationship between the patient activation measure (PAM) and future diabetes-related health outcomes through retrospective analysis of secondary data using multivariate logistic regression. PAM scores from a 2004 survey on 1180 randomly sampled adults with diabetes and health information from a 2006 diabetes registry were the data sources used. The PAM was predictive for hemoglobin A1c (HgA1c) testing (P < .008), low-density lipoprotein cholesterol (LDL-C) testing (P < .005), HgA1c control (P < .01), and all-cause discharges (P < .03), but not for lipid-lowering drug use, LDL-C control, or acute myocardial infarction discharges. These results suggest that PAM scores can be used to identify patients at risk for poorer health outcomes.
Citation format
REMMERS, Carol L, et al. Is patient activation associated with future health outcomes and healthcare utilization among patients with diabetes? JOURNAL OF AMBULATORY CARE MANAGEMENT, 2009, 32: 320–327.